High susceptibility to cerebral ischemia in GFAP-null mice.
about
EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophyRational modulation of the innate immune system for neuroprotection in ischemic strokeTargeting Glial Mitochondrial Function for Protection from Cerebral Ischemia: Relevance, Mechanisms, and the Role of MicroRNAsReactive astrocytes and therapeutic potential in focal ischemic strokeMiniaturization: an overview of biotechnologies for monitoring the physiology and pathophysiology of rodent animal models.Electroacupuncture attenuates cervical spinal cord injury following cerebral ischemia/reperfusion in stroke-prone renovascular hypertensive ratsType 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum.GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease.The neuroprotective effect of post ischemic brief mild hypothermic treatment correlates with apoptosis, but not with gliosis in endothelin-1 treated rats.Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury.Electric stimulation of the ears ameliorated learning and memory impairment in rats with cerebral ischemia-reperfusion injury.Paeonia lactiflora Extract Attenuating Cerebral Ischemia and Arterial Intimal Hyperplasia Is Mediated by Paeoniflorin via Modulation of VSMC Migration and Ras/MEK/ERK Signaling PathwayImmediate Remote Ischemic Postconditioning Reduces Brain Nitrotyrosine Formation in a Piglet Asphyxia ModelOverexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia.Astrocyte responses after neonatal ischemia: the yin and the yang.Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytesRecent molecular approaches to understanding astrocyte function in vivo.The role of astrocytes in mediating exogenous cell-based restorative therapy for strokeThe potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia.Inflammation in adult and neonatal stroke.Astrocytes: targets for neuroprotection in stroke.Role of GFAP in CNS injuries.Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.Modulation of Synaptic Plasticity by Exercise Training as a Basis for Ischemic Stroke Rehabilitation.Protective upregulation of activating transcription factor-3 against glutamate neurotoxicity in neuronal cells under ischemia.Neuroimmune Response in Ischemic Preconditioning.GDNF is involved in the barrier-inducing effect of enteric glial cells on intestinal epithelial cells under acute ischemia reperfusion stimulation.Neuroprotection by Combined Administration with Maslinic Acid, a Natural Product from Olea europaea, and MK-801 in the Cerebral Ischemia Model.Role of astrocyte activation in fine particulate matter-enhancement of existing ischemic stroke in Sprague-Dawley male rats.Neuronal Regeneration after Electroacupuncture Treatment in Ischemia-Reperfusion-Injured Cerebral Infarction RatsBone morphogenetic protein 7 upregulates the expression of nestin and glial fibrillary acidic protein in rats with cerebral ischemia-reperfusion injury.c-Jun N-terminal kinase controls a negative loop in the regulation of glial fibrillary acidic protein expression by retinoic acid.Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice.Glutamine synthetase in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer's disease is not affected by pathological progression.Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway.Interleukin-10 overexpression does not synergize with the neuroprotective action of RGD-containing vectors after postnatal brain excitotoxicity but modulates the main inflammatory cell responses.Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease.Correction to: Neuroimmune Response in Ischemic Preconditioning.GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.Distribution of phosphorylated glial fibrillary acidic protein in the mouse central nervous system.
P2860
Q24295527-0892855A-A4F6-4E51-BE2F-C968872D214EQ26851831-14D42A19-CE64-4EE1-8EFA-68E7EC4EB7B6Q28079891-38317365-ACF5-4809-A9C3-B76DF0B1DA40Q28393830-AFD6CCA7-B3EE-4305-9C88-76D20E506D62Q31095403-C1F05D92-6474-4E07-A1E2-C2A092B9B08AQ33706292-512D44E1-888C-4FC2-8F3D-7471A6BA4BB3Q34259303-F14B244E-CC1B-4B87-A2F0-C2D397DCAF92Q34388949-EE60C5B2-43DC-4C58-A6E1-0B57AB647C1EQ34392735-AEABE222-B3F1-42CC-AAE0-BBBBB5905744Q34944470-5F6AF5B6-A6A9-4CB6-8892-F83BFC5BE50EQ36548976-61702C91-C7BC-48A1-9472-D8BB5A853C9CQ36933273-4832D6A0-7E3D-4AD6-BAB1-807069392912Q37030431-B88F6A69-D8F8-41C4-8F74-B75B3E9BDE59Q37149878-8EE7198F-9451-488C-89F7-4CDE80655CD9Q37210804-84906895-AFF8-4E9D-A103-C3DA3E6A4030Q37252016-0BEA261A-4469-4D8C-8D31-29C8927A4F46Q37412106-7313B5FC-1FFE-4256-805B-84E446848D30Q37627332-A9D538B5-F125-4DA5-AE9A-16ACBE132FF3Q37637177-AC6F8AC6-570B-451C-B2BA-4A41F11893B7Q37714376-C49ADCA7-E8E4-4EDB-AD31-32D3DEE1A849Q37869174-10CB2E7B-2C14-4D9B-BDD9-0ADB0F98FDA7Q38186427-8196604D-6FF1-41AC-A211-4EE7E11B4084Q38603996-AB12E2C5-C0A2-49C3-8C21-031BCAD91E53Q38748243-5F10D026-1C05-4700-958A-06C6A5118DC6Q38792104-2C71BF94-44C8-46D9-AB39-33E414FB06DAQ38927962-AA756142-FBAE-42B4-B815-2B877C4F0468Q38989963-22C940CF-3FBF-4C68-AE1C-6CEF461A1CE6Q39467116-5150E5A2-C88C-4A07-BA31-13F1E09FED8FQ39706207-658F62B2-B19D-435F-9319-6217C7AD330AQ41621920-7219874A-E327-4C55-8CD9-CA2AD836ECEDQ41860230-DB9DACB1-1D11-4CE7-8D9F-67FF6A85610EQ42063963-3BC89B23-7A41-4FD0-9E89-C05FAEFCFF89Q42854732-6F214379-491E-4540-A02D-D81C13006AC9Q44275222-752265C9-C021-491E-803D-843D201B77BFQ44530869-354E82F8-6AA1-42D5-8128-690B4C1BC004Q45873376-B7F6CA7B-DC62-49EC-9076-AE1AD2B3AEF8Q47308800-9BBB1491-B60F-43A2-AB1A-1EDEC7E3C9DBQ47982879-3030B730-7238-43E1-887E-637CB0C0DBD8Q48301661-C6DF18E0-18A0-4009-B02B-F1F43B651B2BQ48648717-95C974C3-B6F2-470E-86BD-E071FBD41BDA
P2860
High susceptibility to cerebral ischemia in GFAP-null mice.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
High susceptibility to cerebral ischemia in GFAP-null mice.
@ast
High susceptibility to cerebral ischemia in GFAP-null mice.
@en
type
label
High susceptibility to cerebral ischemia in GFAP-null mice.
@ast
High susceptibility to cerebral ischemia in GFAP-null mice.
@en
prefLabel
High susceptibility to cerebral ischemia in GFAP-null mice.
@ast
High susceptibility to cerebral ischemia in GFAP-null mice.
@en
P2093
P2860
P1476
High susceptibility to cerebral ischemia in GFAP-null mice.
@en
P2093
P2860
P304
P356
10.1097/00004647-200007000-00003
P577
2000-07-01T00:00:00Z
P5875
P6179
1046319305